Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy
2003; Springer Nature; Volume: 22; Issue: 23 Linguagem: Inglês
10.1038/sj.onc.1206417
ISSN1476-5594
AutoresTristan R. McKay, Stephen Bell, Tencho Tenev, Viola Stoll, Rita Lopes, Nicholas R. Lemoine, Iain A. McNeish,
Tópico(s)CRISPR and Genetic Engineering
Referência(s)